Literature DB >> 16091596

Characterization of wheat germ agglutinin ligand on soluble glycoproteins in Caenorhabditis elegans.

Shunji Natsuka1, Masahumi Kawaguchi, Yukiko Wada, Akira Ichikawa, Koji Ikura, Sumihiro Hase.   

Abstract

Some mutants of Caenorhabditis elegans show altered patterns of ectopic binding with wheat germ agglutinin (WGA). Some of these mutants also have defects of morphogenesis and movement during development. To clarify the structures of WGA-ligands in C. elegans that may be involved in developmental events, we have analyzed glycan structures capable of binding WGA. We isolated glycoproteins from wild-type C. elegans by WGA-affinity chromatography, and analyzed their glycan structures by a combination of hydrazine degradation and fluorescent labeling. The glycoproteins had oligomannose-type and complex-type N-glycans that included agalacto-biantenna and agalacto-tetraantenna glycans. Although the complex-type glycans carried beta-GlcNAc residues at their non-reducing ends, they did not bind to the WGA-agarose-resin. Thus, it was suggested that these N-glycans were not responsible for WGA-binding of the isolated glycoproteins. Hydrazinolysis of the glycoproteins also released a considerable amount of GalNAc monosaccharide. It was surmised that N-acetylgalactosamine was derived from mucin-type O-glycans with the Tn-antigen structure (GalNAcalpha1-O-Ser/Thr). WGA-blotting assay of neoglycoproteins revealed that a cluster of Tn-antigens was a good ligand for WGA. These results suggested that the WGA-ligand in C. elegans is a cluster of alpha-GalNAc monosaccharides linked to mucin-like glycoprotein(s). The observations reported in this paper emphasize the possible significance of mucin-type O-glycans in the development of a multicellular organism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091596     DOI: 10.1093/jb/mvi117

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Multiple post-translational modifications regulate E-cadherin transport during apoptosis.

Authors:  Fei Geng; Weijia Zhu; Richard A Anderson; Brian Leber; David W Andrews
Journal:  J Cell Sci       Date:  2012-02-28       Impact factor: 5.285

2.  CBD-1 organizes two independent complexes required for eggshell vitelline layer formation and egg activation in C. elegans.

Authors:  Delfina P González; Helen V Lamb; Diana Partida; Zachary T Wilson; Marie-Claire Harrison; Julián A Prieto; James J Moresco; Jolene K Diedrich; John R Yates; Sara K Olson
Journal:  Dev Biol       Date:  2018-08-16       Impact factor: 3.582

3.  MLT-10 defines a family of DUF644 and proline-rich repeat proteins involved in the molting cycle of Caenorhabditis elegans.

Authors:  Vijaykumar S Meli; Beatriz Osuna; Gary Ruvkun; Alison R Frand
Journal:  Mol Biol Cell       Date:  2010-03-24       Impact factor: 4.138

4.  The eggshell is required for meiotic fidelity, polar-body extrusion and polarization of the C. elegans embryo.

Authors:  Wendy L Johnston; Aldis Krizus; James W Dennis
Journal:  BMC Biol       Date:  2006-10-16       Impact factor: 7.431

Review 5.  Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy.

Authors:  Guillaume Poiroux; Annick Barre; Els J M van Damme; Hervé Benoist; Pierre Rougé
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

6.  Hierarchical assembly of the eggshell and permeability barrier in C. elegans.

Authors:  Sara K Olson; Garrett Greenan; Arshad Desai; Thomas Müller-Reichert; Karen Oegema
Journal:  J Cell Biol       Date:  2012-08-20       Impact factor: 10.539

7.  A biologically active peptide mimetic of N-acetylgalactosamine/galactose.

Authors:  Laura L Eggink; J Kenneth Hoober
Journal:  BMC Res Notes       Date:  2009-02-11

8.  Regulation of extracellular matrix organization by BMP signaling in Caenorhabditis elegans.

Authors:  Robbie D Schultz; Emily E Bennett; E Ann Ellis; Tina L Gumienny
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.